AAA
CBAY
Affinity Asset Advisors’s Cymabay Therapeutics CBAY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-1,090,441
| Closed | -$25.8M | – | 108 |
|
|
2023
Q4 | $25.8M | Sell |
1,090,441
-38,935
| -3% | -$920K | 4.7% | 3 |
|
|
2023
Q3 | $16.8M | Buy |
1,129,376
+79,258
| +8% | +$1.18M | 4.74% | 3 |
|
|
2023
Q2 | $11.5M | Sell |
1,050,118
-33,000
| -3% | -$361K | 4.02% | 7 |
|
|
2023
Q1 | $9.44M | Sell |
1,083,118
-60,413
| -5% | -$527K | 3.12% | 6 |
|
|
2022
Q4 | $7.17M | Sell |
1,143,531
-146,980
| -11% | -$922K | 2.81% | 11 |
|
|
2022
Q3 | $4.52M | Sell |
1,290,511
-81,733
| -6% | -$286K | 1.26% | 17 |
|
|
2022
Q2 | $4.05M | Buy |
1,372,244
+100,000
| +8% | +$295K | 1.71% | 18 |
|
|
2022
Q1 | $3.96M | Buy |
1,272,244
+150,000
| +13% | +$467K | 0.63% | 24 |
|
|
2021
Q4 | $3.79M | Buy |
+1,122,244
| New | +$3.79M | 1.38% | 27 |
|